Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition

被引:29
|
作者
Li, Se-Ruo [1 ]
Tan, Zhu-Xia [1 ]
Chen, Yuan-Hua [2 ]
Hu, Biao [1 ]
Zhang, Cheng [2 ]
Wang, Hua [2 ]
Zhao, Hui [1 ]
Xu, De-Xiang [2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Dept Toxicol, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Pulmonary fibrosis; Vitamin D deficiency; Epithelial-mesenchymal transition; Bleomycin; Mice; COGNITIVE DECLINE; PATHOGENESIS; INHIBITION; INJURY; RISK;
D O I
10.1186/s12931-019-1232-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Our earlier report indicated that active vitamin D3 inhibited epithelial-mesenchymal transition (EMT) in bleomycin (BLM)-induced pulmonary fibrosis. The objective of this study was to further investigate whether vitamin D deficiency exacerbates BLM-induced pulmonary fibrosis. Methods This study consists of two independent experiments. Experiment 1, male mice were fed with vitamin D deficient (VDD) fodder. Experiment 2, Cyp27b1(+/+), Cyp27b1(+/-) and Cyp27b1(-/-) mice were fed with standard diet. For pulmonary fibrosis, mice were intratracheally instilled with a single dose of BLM (1.5 mg/kg). Serum 25(OH) D level was measured. Pulmonary collagen deposition was assessed by Sirius red staining. EMT was measured and transforming growth factor-beta (TGF-beta)/Smad3 signaling was evaluated in the lungs of BLM-treated mice. Results The relative weight of lungs was elevated in BLM-treated mice. Col1 alpha 1 and Col1 alpha 2, two collagen protein genes, were upregulated, and collagen deposition, as determined by Sirius red staining, was observed in the lungs of BLM-treated mice. E-cadherin, an epithelial marker, was downregulated. By contrast, vimentin and alpha-SMA, two EMT markers, were upregulated in the lungs of BLM-treated mice. Pulmonary TGF-beta/Smad3 signaling was activated in BLM-induced lung fibrosis. Further analysis showed that feeding VDD diet, leading to vitamin D deficiency, aggravated elevation of BLM-induced relative lung weight. Moreover, feeding VDD diet aggravated BLM-induced TGF-beta/Smad3 activation and subsequent EMT in the lungs. In addition, feeding VDD diet exacerbated BLM-induced pulmonary fibrosis. Additional experiment showed that Cyp27b1 gene knockout, leading to active vitamin D3 deficiency, exacerbated BLM-induced pulmonary fibrosis. Moreover, Cyp27b1 gene knockout aggravated pulmonary TGF-beta/Smad2/3 activation and subsequent EMT in BLM-induced lung fibrosis. Conclusion Vitamin D deficiency exacerbates BLM-induced pulmonary fibrosis partially through aggravating TGF-beta/Smad2/3-mediated EMT in the lungs.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway
    Guirong Li
    Chenyou Shen
    Dong Wei
    Xusheng Yang
    Cheng Jiang
    Xiucheng Yang
    Wenjun Mao
    Jian Zou
    Jianxin Tan
    Jingyu Chen
    Lung, 2023, 201 : 235 - 242
  • [32] Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-1/Smad Pathway and Epithelial to Mesenchymal Transition
    Meng, Lihong
    Zhang, Xiaomei
    Wang, Hong
    Dong, Huan
    Gu, Xiaofeng
    Yu, Xiaolin
    Liu, Yushan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [33] Regulation of Transforming Growth Factor-/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis
    Divya, Thomas
    Velavan, Bakthavatchalam
    Sudhandiran, Ganapasam
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (02) : 122 - 129
  • [34] NecroX-5 ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3-mediated epithelial-mesenchymal transition
    Li Min
    Zhang Shu-Li
    Yuan Feng
    Hu Han
    Li Shao-Jun
    Tong Sheng-Xiong
    Tian Jia-Yu
    Fang Xiang-Zhi
    Feng Dan
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [35] SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
    Wang, Shanshan
    You, Xin
    Liu, Xiaoshu
    Zhang, Fengwei
    Zhou, Hongjuan
    Shang, Xuechai
    Cai, Long
    ISCIENCE, 2023, 26 (07)
  • [36] Silencing FHL2 inhibits bleomycin-induced pulmonary fibrosis through the TGF-β1/Smad signaling pathway
    Shi, Mengkun
    Cui, Huixia
    Shi, Jialun
    Mei, Yunqing
    EXPERIMENTAL CELL RESEARCH, 2023, 423 (02)
  • [37] Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
    Ruijuan Guan
    Xia Wang
    Xiaomei Zhao
    Nana Song
    Jimin Zhu
    Jijiang Wang
    Jin Wang
    Chunmei Xia
    Yonghua Chen
    Danian Zhu
    Linlin Shen
    Scientific Reports, 6
  • [38] Oleanolic Acid Acetate Alleviates Bleomycin-Induced Pulmonary Fibrosis Via Inhibiting Epithelial-Mesenchymal Transition
    Jung, J.
    Jeong, E.
    Hwang, K.
    Park, C.
    Lim, H.
    Kim, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [39] Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition
    Liu, Yuan
    Liu, Bing
    Zhang, Gu-qin
    Zou, Jing-feng
    Zou, Meng-lin
    Cheng, Zhen-shun
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 (07) : 695 - 704
  • [40] Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway
    Jia, Li
    Sun, Ping
    Gao, Hui
    Shen, Jie
    Gao, Yuan
    Meng, Cheng
    Fu, Shidong
    Yao, Huijuan
    Zhang, Gong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (06) : 1017 - 1028